3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sleep Initiation and Maintenance Disorders
8
Anxiety Disorders
6
Neoplasms
5
Fatigue
4
Lymphoma
3
Depression
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Nervous System Diseases
2
Lymphoma, Follicular
2
Glioma
2
Weight Loss
1
Weight Gain
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Mental Disorders
1
Meningioma
1
Melanoma
1
Medication Adherence
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Interventions
rozanolixizumab
8
zilucoplan
7
ravulizumab
6
fludarabine
5
efgartigimod alfa
5
Cyclophosphamide
5
telitacicept
3
Prednisone
3
inebilizumab
2
Rituximab
2
Pyridostigmine Bromide
2
tofacitinib
1
thymoglobulin
1
talquetamab
1
remibrutinib
1
prednylidene
1
iptacopan
1
eculizumab
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Walk Test
1
Therapeutics
1
Tacrolimus
1
Steroids
1
Robotic Surgical Procedures
1
Psychodrama
1
Prednisolone
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Oxaloacetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
Cognitive Behavioral Therapy
×
1 year
×
Clear all
NCT06659627
2025-09-09
FIT to ACT-MG
Leiden University Medical Center
Phase NA
Recruiting
60 enrolled